Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice

Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke

(2015) Ahmed Alhusban et al.   JOURNAL OF HYPERTENSION

Direct Stimulation of Angiotensin II Type 2 Receptor Initiated After Stroke Ameliorates Ischemic Brain Damage

(2014) Li-Juan Min et al.   AMERICAN JOURNAL OF HYPERTENSION

The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke

(2014) Jason P. Joseph et al.   NEUROPHARMACOLOGY

Direct Angiotensin AT2 Receptor Stimulation Using a Novel AT2 Receptor Agonist, Compound 21, Evokes Neuroprotection in Conscious Hypertensive Rats

(2014) Claudia A. McCarthy et al.   PLoS One

Protective arms of the renin-angiotensin-system in neurological disease

(2013) Colin Sumners et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Angiotensin II Type 2 Receptor Stimulation Initiated After Stroke Causes Neuroprotection in Conscious Rats

(2012) Claudia A. McCarthy et al.   HYPERTENSION

AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression

(2012) Pawel Namsolleck et al.   NEUROBIOLOGY OF DISEASE

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

(2011) Alan H. Nagahara et al.   NATURE REVIEWS DRUG DISCOVERY

Non-peptide AT2-receptor agonists

(2010) U Muscha Steckelings et al.   CURRENT OPINION IN PHARMACOLOGY

Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage

(2009) Paolo Gelosa et al.   JOURNAL OF HYPERTENSION

Angiotensin AT 2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke

(2009) Claudia A. McCarthy et al.   STROKE